title: Probing the epigenome.
authors.affiliation: Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Andrea
authors.initials: A
authors.lastname: Huston
authors.affiliation: 1] Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. [2] Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. [3] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Cheryl H
authors.initials: CH
authors.lastname: Arrowsmith
authors.affiliation: 1] Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. [2] Target Discovery Institute, University of Oxford, Oxford, UK. [3] Structural Genomic Consortium, University of Oxford, Oxford, UK. [4] Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Knapp
authors.affiliation: 1] Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. [2] Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Schapira
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D035843:Biomedical Research / Q000639:trends; D002843:Chromatin; D016503:Drug Delivery Systems; D044127:Epigenesis, Genetic; D057890:Epigenomics / Q000379:methods* / Q000639:trends; D005819:Genetic Markers; D015894:Genome, Human; D055106:Genome-Wide Association Study; D006801:Humans; D015335:Molecular Probes / Q000138:chemical synthesis / Q000627:therapeutic use; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D002843:Chromatin; D005819:Genetic Markers; D015335:Molecular Probes; D009363:Neoplasm Proteins; D034741:RNA, Small Interfering